Systematic review and meta-analysis of 51 studies (34,623 patients) after stopping anticoagulation for VTE: APS, antithrombin deficiency, homozygous FVL and compound FVL/PTM were associated with roughly 2–3-fold recurrence risk; heterozygous FVL or PTM about 1.5-fold.
Meta-analysisn = 34,623
Vrotniakaite-Bajerciene et al. Recurrent VTE in patients with thrombophilia after stopping anticoagulation: a systematic review and meta-analysis